FDA issues safety alert on breast implant-associated cancers
The Food and Drug Administration yesterday alerted health care providers and the public to reports of squamous cell carcinoma in scar tissue around breast implants, as well as lymphomas different than those previously associated with breast implants. The agency recommends that health care providers continue to report cancers around breast implants to help it identify and better understand this emerging issue.
Related News Articles
Chairperson's File
The connection between a hospital and its community is special. Hospitals are woven into the fabric of their communities, and working together, hospitals and…
Headline
The AHA’s Hospital Community Collaborative has launched the HCC Academy, with specialized workshops for leaders from hospitals, health systems and community…
Headline
The AHA Aug. 6 released the first poster of the People Matter, Words Matter series to be translated into Spanish. Las Personas Importan, Las Palabras Importan…
Headline
Mary Thompson — a member of AHA’s Committee on Behavioral Health and president of Trillium Place, a mental health and addiction recovery organization…
Headline
Pennsylvania Hospital CEO Alicia Gresham takes pride in being the first African American CEO of the nation's first hospital and writes about the importance of…
Blog
More than 16 years ago, the U.S. House of Representatives designated July as National Minority Mental Health Awareness Month. Inspired by the work of author…